Back to Top

International Psychogeriatrics

International Psychogeriatrics is the official journal of the International Psychogeriatric Association. It is a multidisciplinary, peer-reviewed journal for researchers, clinicians, and educators in the field of psychogeriatrics. The journal emphasis is on an integrated and broadly encompassing approach to older people, which considers physical and mental health and illness, as well as psychosocial factors and societal perspectives. During the past four years, the journal has increased its frequency from bimonthly to monthly; the 2015 impact factor is 2.22.

The Editor-in-Chief invites submission of original research articles, literature reviews, case reports and letters to the editor. Editorials and book reviews are commissioned directly by the Editor-in-Chief. All articles must be original material, not previously published in English and not currently under consideration for publication elsewhere.

International Psychogeriatrics is published twelve times per year.  A subscription is included with each IPA membership. The journal often receives grants and support for special focused supplement issues. IPA members receive these issues at no additional charge.

Here are some examples of the high caliber material in International Psychogeriatrics:

Bruscoli, M., and Lovestone, S. (2004). Is MCI really just early dementia? A systematic review of conversion studies. International Psychogeriatrics, 16, 129-140.

Ellis, K. A., Bush, A. I., Darby, D., De Fazio, D., Foster, J., Hudson, P., et al. (2009). The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease. International Psychogeriatrics, 21, 672-687.

Filan, S. L., and  Llewellyn-Jones, R. H. (2006). Animal-assisted therapy for dementia: a review of the literature. International Psychogeriatrics, 18, 597-611.

Grace, J., Daniel, S., Stevens, T., Shankar, K., Walker, Z., Byrne, E. J., et al. (2001). Long-Term Use of Rivastigmine in Patients With Dementia with Lewy Bodies: An Open-Label Trial. International Psychogeriatrics, 13, 199-205.

Instructions for contributors, copies of all published issues as well as some forthcoming articles and additional information about the journal can be found at our Cambridge University Press website:

Nicola T. Lautenschlager
University of Melbourne Department of Psychiatry
Professor of Psychiatry of Old Age
Academic Unit for Psychiatry of Old Age
Normanby Unit, St. Vincent’s Aged Mental Health Service
St. George’s Hospital Campus (St. Vincent’s Hospital)
283 Cotham Road, Kew, Victoria, 3101, Australia


Christina Bryant
Psychological Sciences
The University of Melbourne
Melbourne, Vic 3010 Australia

Constantine (Kostas) Lyketsos
Elizabeth Plank Althouse Professor
Johns Hopkins University
5300 Alpha Commons Drive
Baltimore, MD, 21224, USA

John O’Brien
Foundation Professor of Old Age Psychiatry
Department of Psychiatry
University of Cambridge
Level E4, Box 189
Addenbrooke’s Hospital
Hills Road
Cambridge CB2 0QQ, UK

Guk-Hee Suh
Professor of Psychiatry
Hallym University Medical Center
Hangang Sacred Heart Hospital
94-200 Yungdeungpo-Dong
Seoul, South Korea 150-030

Kate Filipiak
IPA Executive Director

David Ames
Manfred Bergener
Gene Cohen
Robin Eastwood
Sanford Finkel
Kazuo Hasegawa
Akira Homma


VCambridge University Press